Microplastics in Cosmetics: How Labs Test for Them and What the Regulations Actually Require

The EU’s REACH restriction on intentionally added microplastics — Commission Regulation (EU) 2023/2055 — entered into force in October 2023, and transition clocks for cosmetic products are running. For rinse-off and most leave-on formulas, that window is roughly four years from the restriction date, pointing to an October 2027 deadline. We’re well past the halfway mark, and a significant portion of brands exporting to European markets still haven’t conducted a full ingredient-level audit to understand their exposure.

That’s not always negligence. Part of the problem is that the testing science for microplastics in cosmetic matrices remains genuinely messy. Unlike heavy metals testing — where you run ICP-MS against established limits, compare to specifications, and issue a report — there’s no universally harmonized analytical method for microplastic detection in a 30-ingredient emulsion or a pressed powder compact. Labs, brands, and regulators are figuring this out together, in real time, while the compliance clock ticks.

Here’s what we actually know: how the testing works, where the methods fall short, and what the regulatory picture looks like as we head deeper into 2026.

What “Microplastics in Cosmetics” Actually Covers — It’s Not Just Exfoliating Beads

Most people’s mental model of cosmetic microplastics is the small polyethylene beads that used to appear in facial scrubs. Those were the obvious target of the US Microbead-Free Waters Act of 2015, which banned the manufacture and sale of rinse-off cosmetics containing intentionally added plastic microbeads. That law is narrow by design — solid plastic microbeads, rinse-off products, full stop.

For EU market entry and European regulatory compliance, Care Europe provides expert consulting from Paris.

The EU’s REACH restriction casts a far wider net. It targets any synthetic polymer particle smaller than 5 mm that is insoluble in water, regardless of shape — spherical, irregular, fibrous. That definition sweeps in a long list of ingredients that appear routinely in cosmetic formulations:

• Acrylates copolymer — used as a film former in waterproof sunscreens and mascaras
• Nylon-12 and Nylon-6 — common texture agents in pressed powders and foundations
• Polyurethane-based particles — used in foundation formulas for soft-focus optical effects
• PTFE (polytetrafluoroethylene) — a slip agent in certain pressed and loose powders
• Encapsulated fragrance microcapsules — particles designed to rupture on skin contact and release scent

That last category is where things get particularly complicated. The EU extended transition periods for encapsulated fragrance ingredients specifically because reformulation is genuinely difficult — the microcapsule architecture is the delivery mechanism. Brands using this technology have a longer runway, but it isn’t unlimited, and the ECHA guidance on encapsulated substances runs to dozens of pages on its own.

It’s also worth separating intentional from incidental microplastic contamination. Regulatory frameworks currently target ingredients added deliberately — not polymer particles that enter a formula through manufacturing equipment, packaging migration, or ambient sources. But expect that boundary to get scrutiny as detection methods mature and regulatory appetite grows.

The Three Methods Labs Use — and Where Each One Falls Short

There’s no single gold-standard analytical method for microplastics in cosmetics. What a lab uses depends on whether you need identification, quantification, or both — and what you can realistically do with the matrix you’re working with.

μFT-IR (Micro Fourier Transform Infrared Spectroscopy) is the most widely used identification approach. You’re matching spectral fingerprints of isolated particles against polymer reference libraries to determine composition. Coupled with infrared microscopy, it can resolve particles down to roughly 10–20 μm. The limitation is throughput and sample prep. Stripping a complex emulsion — oils, surfactants, emulsifiers, actives — without destroying or losing the particles you’re trying to characterize is labor-intensive and introduces variability between labs. And because FT-IR counts particles rather than weighs them, translating results into a mass-per-gram figure requires assumptions that add uncertainty.

Raman Spectroscopy (typically micro-Raman) is theoretically more sensitive at smaller particle sizes, down to ~1 μm — useful when you’re working in the range where microplastics blur into nanoplastics. The practical problem is fluorescence interference. Many cosmetic raw materials fluoresce under the laser, and that background signal can completely obscure the polymer spectral peaks you’re looking for. Mitigation strategies exist — shifted excitation wavelengths, fluorescence quenching — but they add complexity and cost. Instrument time is also substantially higher than FT-IR.

Pyrolysis-GC/MS takes a fundamentally different approach. You thermally degrade the sample under controlled conditions and identify the resulting volatile fragments by mass spectrometry, matching them to polymer-specific pyrolysis products. This is the most rigorous path to mass-based quantification — you get a result in micrograms of polymer per gram of product, which is exactly the format that risk assessors and regulators can use. The significant limitation: it’s a destructive technique. The sample is gone after analysis, so there’s no follow-up characterization. And pyrolysis conditions — temperature ramp, atmosphere, sample mass — need to be carefully controlled and reported, because results from different labs using slightly different protocols can vary by a factor of two or more. Harmonization across labs is still a work in progress.

ISO 24187:2023 provides a principles-level framework for microplastic analysis, primarily written for environmental samples — sediments, water, biological tissue. It’s a useful reference document, but it wasn’t designed for the specific matrix challenges of a face cream or a lip gloss. Labs adapting these methods to cosmetics are doing significant in-house method development, which means that right now, a test report from one ISO 17025–accredited lab and a test report from another may not be directly comparable if they used different sample preparation or quantification approaches.

At Qalitex, we’ve developed a tiered approach for cosmetic microplastic work: start with a systematic ingredient review against the ECHA polymer definition to identify candidate substances before any analytical work begins, use μFT-IR for particle characterization and confirmation, and reserve pyrolysis-GC/MS for mass-based quantification where a specific regulatory threshold needs to be demonstrated. It’s not a simple workflow, but it’s the one that produces defensible, traceable data — and that documentation is what you’ll need when a notified body or customs authority comes asking.

Where the Regulations Stand — and the Gap Between Europe and the US

Let’s be precise about the current state, because the regulatory picture varies enormously depending on where you’re selling.

European Union: Commission Regulation (EU) 2023/2055 is in force. It restricts the placing on the market of articles and mixtures in which microplastics have been intentionally added — including cosmetics. Transition periods for most cosmetic product categories run approximately four years from the October 2023 effective date, putting the compliance deadline around October 2027. Products containing encapsulated active ingredients or fragrance microcapsules have longer transitions, in some cases up to 12 years, reflecting the genuine reformulation challenge. The ECHA has published guidance documents totaling well over 100 pages to help companies determine whether their specific ingredients fall under the restriction. Reading those documents carefully — not relying on a supplier’s summary — is the minimum standard of diligence for any brand selling in the EU.

United States: Federal regulation remains narrow. The Microbead-Free Waters Act of 2015 covers solid plastic microbeads in rinse-off personal care products only. The FDA has not issued regulations extending microplastics restrictions to leave-on cosmetics, non-bead particle shapes, or the polymer types that the EU restriction captures. As of early 2026, there’s no federal equivalent of the EU framework.

That asymmetry has real operational consequences. A product formulated entirely for the US market — compliant with every applicable federal and state regulation — may already contain ingredients that are non-compliant for EU export without the brand realizing it. Companies that conduct their ingredient audits solely against the Microbead-Free Waters Act standard are auditing against a decade-old, deliberately narrow definition that captures only a fraction of what’s now regulated in Europe.

California has consistently been the most active US jurisdiction on cosmetic chemical regulation — the California Cosmetics Act, the Toxic-Free Cosmetics Act, and subsequent rulemaking have established a pattern of eventual convergence with EU standards. It’s reasonable to expect some form of state-level microplastics restriction to emerge over the next few years. Brands that reformulate proactively for EU compliance are building a significant head start on whatever comes next domestically.

Start With the Ingredient List, Not the Lab

Before commissioning any analytical testing, pull your INCI list and map every ingredient that could plausibly be a synthetic polymer particle — acrylates copolymers, polyethylene, nylons, polyurethane powders, PTFE, any encapsulated ingredient — against the ECHA’s published criteria. Many will turn out to fall under transition periods, derogations, or explicit exemptions in the regulation. Some won’t, and those are the ones that need attention now.

For anything that isn’t clearly exempt, go to your raw material supplier and ask directly: does this ingredient contain synthetic polymer particles smaller than 5 mm that are insoluble in water? A reputable supplier selling into global markets should have this data already. If they can’t answer the question, that tells you something about the reliability of your supply chain documentation more broadly.

Analytical testing is most valuable for verifying reformulated products and generating compliance records — not for discovery. It’s an expensive, time-consuming way to answer a question your supplier specifications and ECHA guidance should be able to address first.

The brands that will face problems in late 2027 are the ones beginning ingredient reviews in mid-2027. Reformulation timelines, stability testing under ICH guidelines, and label update cycles add up to 12–18 months even when things go smoothly. The window to act without pressure is now — and it won’t be open much longer.